Public Profile

Hospira

Hospira, Inc., a leading global provider of injectable drugs and infusion technologies, is headquartered in the United States. Founded in 2004, the company has established itself as a key player in the pharmaceutical and biotechnology industry, focusing on critical care and hospital products. With major operational regions across North America, Europe, and Asia, Hospira is renowned for its commitment to quality and innovation. The company offers a diverse range of core products, including sterile injectable medications, biosimilars, and advanced infusion systems, which are distinguished by their reliability and safety features. Hospira's market position is bolstered by its notable achievements in enhancing patient care and streamlining hospital operations, making it a trusted partner in healthcare settings worldwide.

DitchCarbon Score

How does Hospira's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Hospira's score of 3 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Hospira's reported carbon emissions

Hospira, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Hospira may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. As such, it will be important for Hospira to establish clear climate goals and transparency in emissions reporting to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hospira's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Hospira is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hospira is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

Drager Medical B.V.

NL
Medical Device Manufacturing
Updated 3 days ago

Mochida Siemens Medical Systems Co., Ltd.

JP
Medical Device Manufacturing
Updated 3 days ago

GE HealthCare

US
Medical Device Manufacturing
Updated 11 days ago

Samsung Electronics Hainan Fiberoptics Korea Co., Ltd.

KR
Medical Device Manufacturing
Updated 3 days ago

Bionic Medizintechnik GmbH

DE
Medical Device Manufacturing
Updated 11 days ago
CDP

Tecan

CH
Medical Device Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers